tiprankstipranks
Trending News
More News >
Pfizer (PFE)
NYSE:PFE
US Market

Pfizer (PFE) Ratios

Compare
33,186 Followers

Pfizer Ratios

PFE's free cash flow for Q4 2024 was $0.67. For the 2024 fiscal year, PFE's free cash flow was decreased by $ and operating cash flow was $0.04. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
1.17 0.91 1.22 1.40 1.35
Quick Ratio
0.92 0.69 1.00 1.19 1.04
Cash Ratio
0.02 0.06 <0.01 0.05 0.07
Solvency Ratio
0.12 0.06 0.36 0.26 0.13
Operating Cash Flow Ratio
0.30 0.18 0.69 0.76 0.56
Short-Term Operating Cash Flow Coverage
1.83 0.84 9.94 14.54 5.33
Net Current Asset Value
$ -74.54B$ -93.88B$ -50.03B$ -44.32B$ -55.69B
Leverage Ratios
Debt-to-Assets Ratio
0.30 0.31 0.18 0.20 0.25
Debt-to-Equity Ratio
0.72 0.80 0.36 0.48 0.61
Debt-to-Capital Ratio
0.42 0.44 0.27 0.32 0.38
Long-Term Debt-to-Capital Ratio
0.39 0.41 0.25 0.31 0.37
Financial Leverage Ratio
2.42 2.54 2.06 2.35 2.44
Debt Service Coverage Ratio
1.81 0.85 9.01 8.19 3.06
Interest Coverage Ratio
4.83 1.52 32.33 19.24 7.34
Debt to Market Cap
0.42 0.44 0.12 0.11 0.19
Interest Debt Per Share
11.78 12.95 6.44 6.84 7.15
Net Debt to EBITDA
3.45 7.11 0.84 1.14 2.77
Profitability Margins
Gross Profit Margin
74.19%49.25%65.77%62.08%79.26%
EBIT Margin
17.47%5.58%35.85%31.50%20.25%
EBITDA Margin
28.49%16.34%40.90%37.88%31.42%
Operating Profit Margin
23.48%5.74%39.90%30.55%25.37%
Pretax Profit Margin
12.61%1.81%34.61%29.91%17.89%
Net Profit Margin
12.62%3.62%31.27%27.04%16.75%
Continuous Operations Profit Margin
12.65%3.71%31.30%27.63%15.91%
Net Income Per EBT
100.10%200.28%90.33%90.41%93.64%
EBT Per EBIT
53.71%31.50%86.76%97.90%70.53%
Return on Assets (ROA)
3.76%0.94%15.91%12.11%4.55%
Return on Equity (ROE)
9.11%2.38%32.79%28.47%11.10%
Return on Capital Employed (ROCE)
8.77%1.88%25.81%17.89%8.28%
Return on Invested Capital (ROIC)
8.45%3.65%23.41%16.27%7.60%
Return on Tangible Assets
8.98%2.26%30.62%20.52%9.22%
Earnings Yield
5.34%1.30%10.92%6.65%3.43%
Efficiency Ratios
Receivables Turnover
4.31 5.23 9.16 7.08 5.30
Payables Turnover
2.91 4.42 5.04 5.53 2.03
Inventory Turnover
1.51 2.91 3.82 3.40 1.08
Fixed Asset Turnover
3.46 2.68 6.17 5.46 3.01
Asset Turnover
0.30 0.26 0.51 0.45 0.27
Working Capital Turnover Ratio
43.85 25.11 7.68 6.21 18.04
Cash Conversion Cycle
200.76 112.52 62.93 92.77 226.94
Days of Sales Outstanding
84.77 69.74 39.84 51.54 68.92
Days of Inventory Outstanding
241.21 125.27 95.45 107.28 337.87
Days of Payables Outstanding
125.22 82.50 72.36 66.06 179.85
Operating Cycle
325.98 195.01 135.29 158.82 406.79
Cash Flow Ratios
Operating Cash Flow Per Share
2.25 1.54 5.22 5.82 2.59
Free Cash Flow Per Share
1.74 0.85 4.64 5.33 2.09
CapEx Per Share
0.51 0.69 0.58 0.48 0.50
Free Cash Flow to Operating Cash Flow
0.77 0.55 0.89 0.92 0.81
Dividend Paid and CapEx Coverage Ratio
1.03 0.66 2.40 2.85 1.28
Capital Expenditure Coverage Ratio
4.38 2.23 9.04 12.02 5.16
Operating Cash Flow Coverage Ratio
0.20 0.12 0.84 0.88 0.38
Operating Cash Flow to Sales Ratio
0.20 0.15 0.29 0.40 0.34
Free Cash Flow Yield
6.55%2.95%9.06%9.03%5.68%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
18.71 76.67 9.16 15.05 29.13
Price-to-Sales (P/S) Ratio
2.36 2.78 2.86 4.07 4.88
Price-to-Book (P/B) Ratio
1.70 1.83 3.00 4.28 3.23
Price-to-Free Cash Flow (P/FCF) Ratio
15.28 33.90 11.04 11.07 17.61
Price-to-Operating Cash Flow Ratio
11.79 18.67 9.82 10.15 14.20
Price-to-Earnings Growth (PEG) Ratio
0.07 -0.82 0.22 0.07 -0.51
Price-to-Fair Value
1.70 1.83 3.00 4.28 3.23
Enterprise Value Multiple
11.74 24.11 7.84 11.88 18.30
EV to EBITDA
11.74 24.11 7.84 11.88 18.30
EV to Sales
3.35 3.94 3.21 4.50 5.75
EV to Free Cash Flow
21.64 48.08 12.36 12.25 20.75
EV to Operating Cash Flow
16.70 26.49 11.00 11.23 16.73
Tangible Book Value Per Share
-6.26 -7.69 0.21 0.56 -2.62
Shareholders’ Equity Per Share
15.57 15.77 17.06 13.78 11.38
Tax and Other Ratios
Effective Tax Rate
>-0.01 -1.05 0.10 0.08 0.06
Revenue Per Share
11.23 10.37 17.89 14.51 7.54
Net Income Per Share
1.42 0.38 5.59 3.92 1.26
Tax Burden
1.00 2.00 0.90 0.90 0.94
Interest Burden
0.72 0.32 0.97 0.95 0.88
Research & Development to Revenue
0.17 0.18 0.11 0.17 0.22
SG&A to Revenue
0.00 0.19 0.11 0.13 0.23
Stock-Based Compensation to Revenue
0.01 <0.01 <0.01 0.01 0.02
Income Quality
1.58 4.01 0.93 1.45 2.05
Currency in USD
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis